Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer

IMPORTANCE: Adjuvant chemotherapy remains the only recommended treatment for patients with triple-negative breast cancer (TNBC). However, the existing evidence is not enough to recommend adjuvant therapies to patients with T1 N0 M0 TNBC. OBJECTIVE: To evaluate the association of different adjuvant t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Zhen, Zheng, Yi, Yao, Jia, Liu, Yu, Ruan, Jian, Deng, Yujiao, Zhou, Linghui, Zhao, Peng, Yang, Si, Hu, Jingjing, We, Bajin, Wu, Ying, Zhang, Dai, Kang, Huafeng, Dai, Zhijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677762/
https://www.ncbi.nlm.nih.gov/pubmed/33211105
http://dx.doi.org/10.1001/jamanetworkopen.2020.21881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677762/
https://www.ncbi.nlm.nih.gov/pubmed/33211105
http://dx.doi.org/10.1001/jamanetworkopen.2020.21881

Ejemplares similares